세계의 비타민 D 요법 시장 규모 조사 및 예측 : 투여 경로별, 구입 패턴별, 용도별, 연령층별, 지역별 분석(2023-2030년)

Global Vitamin D Therapy Market is valued approximately at USD 4.59 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 11.6% over the forecast period 2023-2030. Vitamin D therapy involves to the usage of vitamin D supplements or therapeutic methods to mitigate deficits or oversee health issues related to insufficient amounts of vitamin D. It aims to restore optimal vitamin D levels crucial for bone health, immune function, and overall well-being. Administered through oral supplements, injections, or other forms, vitamin D therapy is prescribed based on individual needs and medical history, often guided by laboratory tests. It is beneficial for populations with limited sun exposure, dietary deficiencies, malabsorption issues, or certain medical conditions. The therapy helps prevent or manage conditions such as osteoporosis, rickets, autoimmune disorders and cardiovascular diseases. Healthcare professionals oversee vitamin D therapy to ensure safe and effective outcomes, emphasizing proper dosage and monitoring to avoid toxicity. The increase in awareness campaigns and initiatives about vitamin D deficiency by the government and manufacturers, rise in incidences of the chronic diseases, and rising consumer preference for preventive healthcare are the most prominent factors that are propelling the market demand across the globe.

In addition, the huge patient pool with sedentary lifestyle and rapidly growing aging population is acting as a catalyzing factor for the market demand at a substantial rate. The aging population is more prone to vitamin D deficiency due to reduced skin synthesis and decreased mobility, increasing the need for vitamin D supplementation and therapy among older adults. According to the World Health Organization (WHO), in 2020, it was expected that aging people around the world accounted for 1 billion, which is projected to reach 1.5 billion by the year 2030 which represents 1 in 6 people are more than 60. Moreover, the rise in technological advancements in formulations, as well as the growing investments in research and development presents various lucrative opportunities over the forecasting years. However, the growing consumption of fortified products and the changes in regulatory scenario are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Vitamin D Therapy Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the growing awareness of vitamin D deficiency, extensive research to develop more patient-friendly products with improved efficacy and the rise in healthcare spending. Also, the decreased physical activity, obesity, and lower social status are associated with low vitamin D levels. For instance, a CDC report from January 2022 revealed that 25% of American adults do not engage in sufficient physical activity for maintaining health. Physical inactivity rates vary across states and territories, ranging from 17.7% in Colorado to 49.4% in Puerto Rico. This decline in physical activity heightens the risk of vitamin D deficiency among individuals, potentially fueling the demand for treatment and bolstering market expansion. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The growing awareness regarding vitamin D deficiency and bolstered by supportive government initiatives aimed at implementing treatment plans for addressing vitamin D deficiency are significantly propelling the market demand across the region. Additionally, factors such as significant air pollution levels, sedentary lifestyles, escalating incidence of vitamin D deficiency, unconventional dietary habits, reduced sun exposure, and rising malnutrition levels contribute to the increasing demand for vitamin D deficiency treatment in the region.

Major market players included in this report are:

• Abbott Laboratories (US)
• Sanofi SE (France)
• GlaxoSmithKline plc (UK)
• Pfizer Inc. (US)
• Merck & Co., Inc. (US)
• Torrent Pharmaceuticals Ltd. (India)
• Novartis International AG (Switzerland)
• Alkem Laboratories (India)
• Sun Pharmaceutical Industries Ltd. (India)
• Cadila Healthcare Ltd (India)

Recent Developments in the Market:

• In August 2022, Arbro Pharmaceuticals introduced Vkap-D3, a plant-based capsule, in India. With a potency of 60,000 IU of Vitamin D3, Vkap-D3 is involved in a unique hard vegetarian liquid-filled capsule shell made of plant-based HPMC. This novel combination is intended to effectively treat vitamin D deficiencies.

Global Vitamin D Therapy Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Route of Administration, Purchasing Pattern, Application, Age Group, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Route of Administration:

• Oral Route
• Parenteral Route

By Purchasing Pattern:

• OTC Drugs
• Prescription Drugs

By Application:

• Osteoporosis
• Rickets
• Skin Diseases
• Muscle Weakness
• Autoimmune Disorders
• Other Applications

By Age Group:

• Children
• Adults
• Senior Adults

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Vitamin D Therapy Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Vitamin D Therapy Market, by Route of Administration, 2020-2030 (USD Billion)
  • 1.2.3. Vitamin D Therapy Market, by Purchasing Pattern, 2020-2030 (USD Billion)
  • 1.2.4. Vitamin D Therapy Market, by Application, 2020-2030 (USD Billion)
  • 1.2.5. Vitamin D Therapy Market, by Age Group, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Vitamin D Therapy Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Vitamin D Therapy Market Dynamics

• 3.1. Vitamin D Therapy Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Huge patient pool with sedentary lifestyle and rapidly growing aging population
    • 3.1.1.2. Rising incidences of the chronic diseases
  • 3.1.2. Market Challenges
    • 3.1.2.1. Growing consumption of fortified products
    • 3.1.2.2. Changes in regulatory scenario
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rise in technological advancements in formulations
    • 3.1.3.2. Growing investments in research and development

Chapter 4. Global Vitamin D Therapy Market: Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economic
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Vitamin D Therapy Market, by Route of Administration

• 5.1. Market Snapshot
• 5.2. Global Vitamin D Therapy Market by Route of Administration, Performance - Potential Analysis
• 5.3. Global Vitamin D Therapy Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
• 5.4. Vitamin D Therapy Market, Sub Segment Analysis
  • 5.4.1. Oral Route
  • 5.4.2. Parenteral Route

Chapter 6. Global Vitamin D Therapy Market, by Purchasing Pattern

• 6.1. Market Snapshot
• 6.2. Global Vitamin D Therapy Market by Purchasing Pattern, Performance- Potential Analysis
• 6.3. Global Vitamin D Therapy Market Estimates & Forecasts by Purchasing Pattern 2020-2030 (USD Billion)
• 6.4. Vitamin D Therapy Market, Sub Segment Analysis
  • 6.4.1. OTC Drugs
  • 6.4.2. Prescription Drugs

Chapter 7. Global Vitamin D Therapy Market, by Application

• 7.1. Market Snapshot
• 7.2. Global Vitamin D Therapy Market by Application, Performance - Potential Analysis
• 7.3. Global Vitamin D Therapy Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 7.4. Vitamin D Therapy Market, Sub Segment Analysis
  • 7.4.1. Osteoporosis
  • 7.4.2. Rickets
  • 7.4.3. Skin Diseases
  • 7.4.4. Muscle Weakness
  • 7.4.5. Autoimmune Disorders
  • 7.4.6. Other Applications

Chapter 8. Vitamin D Therapy Market, by Age Group

• 8.1. Market Snapshot
• 8.2. Global Vitamin D Therapy Market by Age Group, Performance - Potential Analysis
• 8.3. Global Vitamin D Therapy Market Estimates & Forecasts by Age Group 2020-2030 (USD Billion)
• 8.4. Vitamin D Therapy Market, Sub Segment Analysis
  • 8.4.1. Children
  • 8.4.2. Adults
  • 8.4.3. Senior Adults

Chapter 9. Global Vitamin D Therapy Market, Regional Analysis

• 9.1. Top Leading Countries
• 9.2. Top Emerging Countries
• 9.3. Vitamin D Therapy Market, Regional Market Snapshot
• 9.4. North America Vitamin D Therapy Market
  • 9.4.1. U.S. Vitamin D Therapy Market
    • 9.4.1.1. Route of Administration breakdown estimates & forecasts, 2020-2030
    • 9.4.1.2. Purchasing Pattern breakdown estimates & forecasts, 2020-2030
    • 9.4.1.3. Application breakdown estimates & forecasts, 2020-2030
    • 9.4.1.4. Age Group breakdown estimates & forecasts, 2020-2030
  • 9.4.2. Canada Vitamin D Therapy Market
• 9.5. Europe Vitamin D Therapy Market Snapshot
  • 9.5.1. U.K. Vitamin D Therapy Market
  • 9.5.2. Germany Vitamin D Therapy Market
  • 9.5.3. France Vitamin D Therapy Market
  • 9.5.4. Spain Vitamin D Therapy Market
  • 9.5.5. Italy Vitamin D Therapy Market
  • 9.5.6. Rest of Europe Vitamin D Therapy Market
• 9.6. Asia-Pacific Vitamin D Therapy Market Snapshot
  • 9.6.1. China Vitamin D Therapy Market
  • 9.6.2. India Vitamin D Therapy Market
  • 9.6.3. Japan Vitamin D Therapy Market
  • 9.6.4. Australia Vitamin D Therapy Market
  • 9.6.5. South Korea Vitamin D Therapy Market
  • 9.6.6. Rest of Asia Pacific Vitamin D Therapy Market
• 9.7. Latin America Vitamin D Therapy Market Snapshot
  • 9.7.1. Brazil Vitamin D Therapy Market
  • 9.7.2. Mexico Vitamin D Therapy Market
• 9.8. Middle East & Africa Vitamin D Therapy Market
  • 9.8.1. Saudi Arabia Vitamin D Therapy Market
  • 9.8.2. South Africa Vitamin D Therapy Market
  • 9.8.3. Rest of Middle East & Africa Vitamin D Therapy Market

Chapter 10. Competitive Intelligence

• 10.1. Key Company SWOT Analysis
  • 10.1.1. Company 1
  • 10.1.2. Company 2
  • 10.1.3. Company 3
• 10.2. Top Market Strategies
• 10.3. Company Profiles
  • 10.3.1. Abbott Laboratories (US)
    • 10.3.1.1. Key Information
    • 10.3.1.2. Overview
    • 10.3.1.3. Financial (Subject to Data Availability)
    • 10.3.1.4. Product Summary
    • 10.3.1.5. Recent Developments
  • 10.3.2. Sanofi SE (France)
  • 10.3.3. GlaxoSmithKline plc (UK)
  • 10.3.4. Pfizer Inc. (US)
  • 10.3.5. Merck & Co., Inc. (US)
  • 10.3.6. Torrent Pharmaceuticals Ltd. (India)
  • 10.3.7. Novartis International AG (Switzerland)
  • 10.3.8. Alkem Laboratories (India)
  • 10.3.9. Sun Pharmaceutical Industries Ltd. (India)
  • 10.3.10. Cadila Healthcare Ltd (India)

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption